Revelation Biosciences Completes Enrollment And Dosing In First Human Phase 1 Study Of Gemini; Top-Line Data To Include Safety, Tolerability, And Biomarkers; Supports Future Development Across Multiple Indications
Revelation Biosciences Completes Enrollment And Dosing In First Human Phase 1 Study Of Gemini; Top-Line Data To Include Safety, Tolerability, And Biomarkers; Supports Future Development Across Multiple Indications
Revelation生物科技完成Gemini第一階段人體試驗的招募和投藥；首要數據將包括安全性、耐受性和生物標誌物；支持未來在多種適應症中的發展。
Revelation Biosciences Completes Enrollment And Dosing In First Human Phase 1 Study Of Gemini; Top-Line Data To Include Safety, Tolerability, And Biomarkers; Supports Future Development Across Multiple Indications
Revelation生物科技完成Gemini第一階段人體試驗的招募和投藥；首要數據將包括安全性、耐受性和生物標誌物；支持未來在多種適應症中的發展。
資訊熱榜
更新時間